Abstract
Rapid intravenous adminstration of the glycopeptide antibiotic, vancomycin, may cause a hypotensive reaction which can usually be prevented by infusing vancomycin in dilute solutions. The release of histamine from circulating cells such as basophils and tissue mast cells has been implicated in hypotensive reactions since the effects can be prevented by antihistamine pretreatment. The direct effects of vancomycin on histamine release were therefore investigated in rat peritoneal mast cells and rat leukemic basophils (RBL-1 cells). Suspension cultures of mast cells or RBL-1 cells were exposed to vancomycin for 30–60 minutes at concentrations comparable to those infused clinically (2.28 or 4.56 mg/ml). Vancomycin induced a time- and dose-dependent release of histamine into the culture media from both cell types. The reference degranulating agent, Compound 48/80 (CP 48/80), was also shown to induce histamine release from mast cells and RBL-1 cells. Mast cells were significantly more sensitive to vancomycin and CP 48/80 than RBL-1 cells and, unlike RBL-1 cells, were responsive to the inhibitory effects of cromolyn sodium on histamine release. Cromolyn sodium did not inhibit vancomycin-induced histamine release in RBL-1 or mast cells. Morphologically, mast cells exposed to either vancomycin or CP 48/80 exhibited dose-releated degranulation. On the other hand, treatment-related degranulation effects of either vancomycin or CP 48/80 on RBL-1 cells could not be reliably distinguished from controls by qualitative evaluation. Based upon these findings it is concluded that mast cells may represent a more useful model to evaluate the potential of investigational agents to relase histamine and to study mechanisms of histamine release than RBL-1 cells.
Similar content being viewed by others
References
R. E. Polk, D. P. Healy, L. B. Schwartz and D. T. Rock,Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. Journal of Infective-Disease157 (3), 502–507 (1988).
P. A. Southorn, D. J. Plevak, A. J. Wright and W. R. Wilson,Adverse effects of vancomycin administered in the perioperative period. Mayo-Clinic-Proceedings61 (9), 721–724 (1986).
J. H. Levy, N. Kettlekamp, P. Goertz, J. Hermens and C. A. Hirshman,Histamine release by vancomycin: a mechanism for hypotension in man. Anesthesiology67 (1), 122–125 (1987).
D. Lagunoff and T. W. Martin,Agents that release histamine from mast cells. Ann. Rev. Pharmacol. Toxicol.23, 331–351 (1983).
G. W. Read and E. F. Kiefer,Benzalkonium chloride: selective inhibitor of histamine release by compound 48/80 and other polyamines. J. Pharmacol. Exp. Therap.211, 711–715 (1979).
W. D. M. Paton,Histamine release by compounds of simple chemical structure. Pharmacol. Rev.9, 269–328 (1957).
A. Goth,Effects of drugs on mast cells. Adv. Pharmacol.5, 47–78 (1967).
C. Isersky, H. Metzger and D. N. Buell,Cell cycle associated changes in IgE receptor during growth and differentiation of a rat basophilic leukemia cell line. J. Exptl. Med.141, 1147–1162 (1975).
D. N. Buell, B. J. Fowlkes, H. Metzger and C. Isersky,Cell cycle and morphological changes during growth and differentiation of a rat basophilic leukemia cell line. Cancer Research36, 3131–3137 (1976).
G. D. Bloom and O. Haegermark,A study on morphological changes and histamine release induced by compound 48/80 in rat peritoneal mast cells. Exp. Cell Res.40, 637 (1965).
I. Kitchen,Effect of sodium cromoglycate on compound 48/80-induced release of histamine from isolated peritoneal mast cells of the rat. InTextbook of in vitro practical pharmacology. (Ed. Ian Kitchen), pp. 137–139. Blackwell Scientific Publications, Oxford, London, Edinburgh, Boston, Melbourne (1984).
S. H. Snyder, R. Baldessarini and J. Axelrod,A sensitive and specific enzymatic isotopic assay for tissue histamine. Journal of Pharmacology and Experimental Therapeutics253, 544–549 (1966).
M. A. Hayat, InPrinciples and techniques of electron microscopy: biological applications, vol. 1, 2nd ed. p. 57, University Park Press, Baltimore, MD (1981).
SAS User's Guide-Statistics,Version 5. Chapter 20. pp. 433–506. SAS Institute, Inc. Cary, North Carolina (1985).
R. G. D. Steel and J. H. Torrie,Principles and procedures of statistics. pp. 347–349. McGraw-Hill, New York (1960).
W. E. Ehrich,Histamine in mast cells. Science118, 603 (1953).
E. J. Kusner, B. Dubnick and D. J. Herzig,The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells. Journal of Pharmacology and Experimental Therapeutcs184, 41–46 (1973).
W. W. Doglas,Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. InGoodman and Gilman's the pharmacological basis of therapeutics, 7ed. (Eds. A. G. Gilman, L. S. Goodman, T. W. Rall and F. Murad) p. 613, Macmillan Published Co., New York, NY (1985).
W. Lorenz, A. Doenicke, B. Schoning and E. Neugebauer,The role of histamine in adverse reactions to intravenous agents. InAdverse reactions to anaesthetic drugs. (Ed. J. A. Thornton) pp. 169–238, Elsevier/North Holland, Amsterdam (1981).
T. C. Theoharides,Mast cells: the immune gate to the brain. Life Sciences46, 607–617 (1990).
F. L. Pearce,Functional heterogeneity of mast cells from different species and tissues. Klin. Wschr.60, 954–957 (1982).
M. Ennis, W. Lorenz, W. Gerland and J. Heise,Isolation of mast cells from rabbit lung and liver: comparison of histamine release induced by the hypnotics Althesin ® and propanidid. Agents and Actions20, 219–222 (1987).
M. Ennis, E. U. Amon and W. Lorenz,Histamine release from canine lung and liver mast cells induced by radiographic contrast media. Agents and Actions27, 101–106 (1989).
D. Sampson and G. T. Archer,Release of histamine from human basophils. Blood29, 722–736 (1967).
W. B. Shelly and L. Juhlin,In vitro effects of lecithinase A on the cytology of the human basophil. Journal of Laboratory & Clinical Investigation60, 589–597 (1962).
Physicians Desk Reference (PDR),44th Edition 1990. Medical Economics Company, Inc. at Oradell, NJ, pp. 1243–1245.
M. Ennis and W. Lorenz,Modulation of histamine release by fatty acids. A new in vitro model investigating adverse drug reactions in various species. Ann. Fr. Anesth. Reanim.4, 124–128 (1985).
M. P. Leite, C. R. deMoraes and J. C. Leme,In vitro and in vivo release of histamine by contrast media in the rat. Acta Radiologica Diagnosis16, 172–180 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, P.D., Laska, D.A., Shetler, T.J. et al. Vancomycin-induced release of histamine from rat peritoneal mast cells and a rat basophil cell line (RBL-1). Agents and Actions 32, 217–223 (1991). https://doi.org/10.1007/BF01980877
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01980877